Xiangdong Xue
Shanghai Jiao Tong University
H-index: 30
Asia-China
Top articles of Xiangdong Xue
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Biomimetic Lung-Targeting Nanoparticles with Antioxidative and Nrf2 Activating Properties for Treating Ischemia/Reperfusion-Induced Acute Lung Injury | Nano Letters | Yanjun Wang Hui Dong Haijing Qu Wei Cheng Han Chen | 2024/1/16 |
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives | Yuqing Pan Xiangdong Xue* Xing‐Jie Liang* | 2024 | |
Drug-drug conjugates self-assembled nanomedicines triggered photo−/immuno-therapy for synergistic cancer treatments | Journal of Controlled Release | Haijing Qu Longmeng Li Han Chen Menghuan Tang Wei Cheng | 2023/11/1 |
Small‐molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT dual‐inhibiting properties for bladder cancer treatment | Exploration | Guoyin Li Zewen Song Yi Ru Jing Zhang Lianxiang Luo | 2023 |
Conjugates of active pharmaceutical ingredients | 2023/11/23 | ||
A Supramolecular Assembly Strategy for Hydrophilic Drug Delivery towards Synergistic Cancer Treatment | Acta Biomaterialia | Haijing Qu Han Chen Wei Cheng Yanjun Wang Yangyang Xia | 2023/7/1 |
Charge-reversible crosslinked nanoparticle for pro-apoptotic peptide delivery and synergistic photodynamic cancer therapy | Nano Research | Haijing Qu Han Chen Wei Cheng Yuqing Pan Zhiran Duan | 2023/12 |
A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers | Biomaterials | Xiangdong Xue Haijing Qu Ruonan Bo Dalin Zhang Zheng Zhu | 2023/8/1 |
Deep tumor-penetrating nano-delivery strategy to improve diagnosis and therapy in patient-derived xenograft (PDX) oral cancer model and patient tissue | Nano Research | Longmeng Li Aaron R Lindstrom Andrew C Birkeland Menghuan Tang Tzu-Yin Lin | 2023/2 |
Uncovering the Fate and Risks of Intravenously Injected Prussian Blue Nanoparticles in mice by an Integrated Methodology of Toxicology, Pharmacokinetics, Proteomics, and … | Particle and Fibre Toxicology | Haijing Qu Xing Jin Wei Cheng Dongqi Wu Boyu Ma | 2023/12 |
Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment | Journal of Controlled Release | Haijing Qu Jinfan Yang Shuaijun Li Ji Xu Xin Zhou | 2023/5/1 |
Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy | Journal of Nanobiotechnology | Ting Zhao Ce Liang Yanrong Zhao Xiangdong Xue Zhao Ma | 2022/4/2 |
1356 Transcriptional profiling of Bicycle® tumor-targeted CD137 agonist-treated mouse tumors revealed an early and rapid activation of myeloid cells followed by infiltration of … | Johanna Lahdenranta Kristen Hurov Heather Cohen Punit Upadhyaya Kevin McDonnell | 2022/11/1 | |
Stimuli‐responsive crosslinked nanomedicine for cancer treatment | Xiangdong Xue Haijing Qu Yuanpei Li | 2022/12 | |
On-demand targeting nanotheranostics with stimuli-responsive releasing property to improve delivery efficiency to cancer | Biomaterials | Hongwei Lu Ji Xu Jinfan Yang Zhongling Wang Peng Xu | 2022/11/1 |
Nanotechnology-based combinatorial phototherapy for enhanced cancer treatment | Han Chen Peter Timashev Yuanyuan Zhang Xiangdong Xue* Xing-Jie Liang* | 2022 | |
Phototherapy with cancer-specific nanoporphyrin potentiates immunotherapy in bladder cancer | Clinical Cancer Research | Zheng Zhu Ai-Hong Ma Hongyong Zhang Tzu-Yin Lin Xiangdong Xue | 2022/8/3 |
Blood–brain barrier penetrating liposomes with synergistic chemotherapy for glioblastoma treatment | Biomaterials Science | Ying Zhang Haijing Qu Xiangdong Xue* | 2022 |
Iron-crosslinked Rososome with robust stability and high drug loading for synergistic cancer therapy | Journal of controlled release | Xiangdong Xue Marina Ricci Haijing Qu Aaron Lindstrom Dalin Zhang | 2021/1/10 |
Two-way magnetic resonance tuning and enhanced subtraction imaging for non-invasive and quantitative biological imaging | Nature nanotechnology | Zhongling Wang Xiangdong Xue Hongwei Lu Yixuan He Ziwei Lu | 2020/6 |
Co-Authors
